Quality and Safety
The ratings, which will be released in July, will not impact 2022 payment determinations, CMS says.
The FDA is looking at additional data on a booster dose in children 6 months to 4 years old.
AHIP agreed that more clinical-trial-based evidence is needed on Aduhelm's benefits and the potential risks to patients.
The Eli Lilly drug awaits emergency use authorization from the FDA.
An effective way to combat workplace injury and illness, said OSHA, is to create and use a proactive safety and health program.
The biggest noncompliance was non-posting or incomplete posting of all of the negotiated prices for each item and service.
SD Biosensor said it has initiated an investigation to determine how the product was illegally imported into the U.S.
Most patients responded well to medication and/or psychotherapy - sometimes called 'talk therapy' - for their condition.
The money is going to eight community organizations serving underserved areas to boost vaccine confidence.
Racial and ethnic minority enrollees reported significantly worse experiences on four key metrics, most revolving around care access.